Experience in using levodopa-benserazide

Experience in using levodopa-benserazide

Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper considers the mechanism of action, recommended levodopa doses, the time of therapy initiation, and risk factors for motor complications. A few dosage forms of levodopa are currently being used. The resu...

Full description

Bibliographic Details
Main Authors: Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2015-10-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
levodopa-benserazide
clinical efficacy
parkinson's disease
Online Access:https://nnp.ima-press.net/nnp/article/view/538
Description
Summary:Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper considers the mechanism of action, recommended levodopa doses, the time of therapy initiation, and risk factors for motor complications. A few dosage forms of levodopa are currently being used. The results of comparative trials of levodopa-benserazide and levodopa-carbidopa and the clinical experience with Levodopa/Benserazide-Teva are given. An open-label multicenter trial of Levodopa/Benserazide-Teva has shown its high efficacy and good tolerability.
ISSN:2074-2711
2310-1342

Similar Items